logo

Abbvie (ABBV)



Trade ABBV now with
  Date
  Headline
3/19/2019 8:48:57 AM AbbVie : FDA Places Partial Clinical Hold On Trials On Venetoclax For Investigational Treatment Of Multiple Myeloma
3/7/2019 8:50:09 AM AbbVie Announces Multiple Milestones For Phase 3 CLL14 Venetoclax Study
3/1/2019 7:25:07 AM AbbVie Receives CHMP Positive Opinion For Risankizumab For Moderate To Severe Plaque Psoriasis
2/22/2019 8:06:01 AM AbbVie And Voyager Collaborate To Develop Vectorized Antibodies To Treat Parkinson's Disease And Other Synucleinopathies
2/21/2019 1:26:18 PM AbbVie Declares Quarterly Dividend Of $1.07, Payable May 15/ Record April 15
2/21/2019 1:25:37 PM AbbVie (ABBV) Declares Quarterly Dividend of $ 1.07, Record Date 4/15/2019
2/19/2019 8:32:18 AM AbbVie Announces NDA Accepted For Priority Review For Upadacitinib For Moderate To Severe Rheumatoid Arthritis
1/28/2019 7:12:12 AM AbbVie Announces U.S. FDA Approval Of IMBRUVICA Plus Obinutuzumab
1/25/2019 7:43:40 AM AbbVie Q4 Adjusted EPS, Excluding Specified Items, Up 28.4% To $1.90
1/3/2019 8:39:00 AM AbbVie, Tizona Announce Strategic Collaboration To Develop First-in-Class Immunotherapy For Cancer Targeting CD39
12/20/2018 8:55:04 AM AbbVie Submits NDA To FDA And MAA To EMA For Upadacitinib For Treatment Of Moderate To Severe Rheumatoid Arthritis
12/14/2018 2:15:54 AM BioArctic Outlicenses Its Alpha-synuclein Antibody Portfolio For Parkinson's Disease To AbbVie After Receiving Clearance
12/13/2018 1:06:21 PM AbbVie (ABBV) Announces $5 Bln Stock Repurchase Plan